CEL-SCI (CVM) News Today $0.25 -0.02 (-5.64%) Closing price 05/2/2025 04:00 PM EasternExtended Trading$0.25 +0.00 (+1.20%) As of 05:02 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 Time Period StockNews.com Begins Coverage on CEL-SCI (NYSE:CVM)May 2 at 1:17 AM | americanbankingnews.comCEL-SCI says publication supports strategy to seek early approval for multikineApril 10, 2025 | markets.businessinsider.comNew Study in the Scientific Journal “Cancer Cell” Supports CEL-SCI's Strategy to Seek Early Approval for Multikine in Head and Neck Cancer Based on Pre-Surgical Tumor ResponsesApril 8, 2025 | businesswire.comCEL-SCI publishes new data from Multikine studyMarch 26, 2025 | markets.businessinsider.comCEL-SCI Announces Closing of $2.5 Million OfferingMarch 18, 2025 | finance.yahoo.comCEL-SCI announces pricing of $2.56M common stock offeringMarch 18, 2025 | markets.businessinsider.comCEL-SCI Announces Pricing of $2.5 Million OfferingMarch 17, 2025 | businesswire.comJournal of the American Medical Association (JAMA) Study Provides Further Evidence that CEL-SCI’s Multikine Can Treat Unmet Need in ~70% of Head and Neck Patients Based on PD ...March 15, 2025 | businesswire.comJournal of the American Medical Association (JAMA) Study Provides Further Evidence that CEL-SCI’s Multikine Can Treat Unmet Need in ~70% of Head and Neck Patients Based on PD ...March 15, 2025 | businesswire.comCEL-SCI announces neoadjuvant nivolumab plus chemotherapy study publishedMarch 15, 2025 | markets.businessinsider.comCEL-SCI to initiate Multikine cancer trialFebruary 20, 2025 | markets.businessinsider.comCEL-SCI to Initiate Multikine Confirmatory Phase 3 Cancer TrialFebruary 20, 2025 | businesswire.comCEL-SCI Reports Fiscal Q1 2025 Financial Results: Multikine Shows Pre-Surgical Tumor Elimination and Regression in Just 3 WeeksFebruary 19, 2025 | finance.yahoo.comCVM: Fiscal Year 2024 ResultsFebruary 11, 2025 | finance.yahoo.comCEL-SCI Reports Fiscal 2024 Results: Set to Commence Confirmatory Study That Could Bring New Standard of Care to Head & Neck CancerJanuary 14, 2025 | finance.yahoo.comCEL-SCI (AMEX:CVM) Stock Quotes, Forecast and News SummaryDecember 31, 2024 | benzinga.comWhat's Going On With Cel-Sci Shares Premarket On Monday?December 30, 2024 | benzinga.comCEL-SCI prices $5M public offering at 31c per shareDecember 30, 2024 | markets.businessinsider.comCEL-SCI prices $5 million offeringDecember 30, 2024 | msn.comCel-Sci Stock Slips After Public Offering: Retail's NeutralDecember 30, 2024 | msn.comCEL-SCI Prices Public Offering Of 16.13 Mln Shares At $0.31/shrDecember 29, 2024 | markets.businessinsider.comCEL-SCI Announces Pricing of $5 Million Public OfferingDecember 29, 2024 | businesswire.comCEL-SCI announces common stock offering, no amount givenDecember 27, 2024 | msn.comCEL-SCI Announces Proposed Public Offering of Common StockDecember 27, 2024 | businesswire.comCEL-SCI provides rationale for use of Multikine in head, neck cancer studyDecember 13, 2024 | markets.businessinsider.comCVM: CRO Selected for Registrational TrialDecember 9, 2024 | msn.comU.S. FDA and CEL-SCI Agree on Use of PD-L1 Biomarker to Select Head and Neck Cancer Patients for Marketing Registration Study to Commence Q1 2025November 7, 2024 | finance.yahoo.com3 Interesting Emerging Growth Stock Ideas From the 2024 Think Equity ConferenceNovember 4, 2024 | investing.comCEL-SCI files to sell 1M shares of common stock for holdersOctober 25, 2024 | markets.businessinsider.comUpstream Bio Inc.October 14, 2024 | money.usnews.comCalcium-mediated effect plays key role in cell disposal, researchers discoverOctober 11, 2024 | msn.comCEL-SCI (NYSE:CVM) Trading Down 3.8% - Here's What HappenedCEL-SCI (NYSE:CVM) Stock Price Down 3.8% - Time to Sell?October 11, 2024 | marketbeat.comCEL-SCI Selects Ergomed as CRO as it Gears Up for Confirmatory FDA Registration Study of Multikine® in Head and Neck CancerOctober 1, 2024 | finance.yahoo.comCVM Oct 2024 2.000 callSeptember 21, 2024 | ca.finance.yahoo.comCEL-SCI to Present New Data for Multikine® Head & Neck Cancer Immunotherapy at the European Society for Medical Oncology 2024 CongressSeptember 10, 2024 | finance.yahoo.comCVM Jan 2025 1.500 callAugust 30, 2024 | ca.finance.yahoo.comCVM Sep 2024 1.500 callAugust 29, 2024 | ca.finance.yahoo.comCVM Oct 2024 1.500 callAugust 29, 2024 | ca.finance.yahoo.comCVM Apr 2025 1.000 putAugust 29, 2024 | ca.finance.yahoo.comCVM: Start Your Engines – FDA Green Lights Confirmatory Registration StudyAugust 28, 2024 | finance.yahoo.comCVM Oct 2024 0.500 call (CVM241018C00000500)August 28, 2024 | finance.yahoo.comCVM Oct 2024 1.500 put (CVM241018P00001500)August 28, 2024 | finance.yahoo.comCVM Sep 2024 1.000 callAugust 23, 2024 | ca.finance.yahoo.comPrincipal Investment Grd Corp Actv ETF (IG)August 23, 2024 | uk.finance.yahoo.comBiomotion Sciences.August 21, 2024 | money.usnews.comNew tool simplifies cell tracking data analysisAugust 17, 2024 | msn.comCEL-SCI Corporation Reports Third Quarter Fiscal 2024 Financial ResultsAugust 15, 2024 | stockhouse.com3 Penny Stocks to Watch Now, 7/30/24July 30, 2024 | msn.comCEL-SCI Announces Closing of $10.8 Million OfferingJuly 29, 2024 | finance.yahoo.com(SANSTAR.BO)July 27, 2024 | finance.yahoo.com Get CEL-SCI News Delivered to You Automatically Sign up to receive the latest news and ratings for CVM and its competitors with MarketBeat's FREE daily newsletter. Email Address CVM Media Mentions By Week CVM Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CVM News Sentiment▼0.000.73▲Average Medical News Sentiment CVM News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CVM Articles This Week▼11▲CVM Articles Average Week Get CEL-SCI News Delivered to You Automatically Sign up to receive the latest news and ratings for CVM and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Vaxart News Today Zentalis Pharmaceuticals News Today Sagimet Biosciences News Today Genelux News Today Zura Bio News Today Atossa Therapeutics News Today Senti Biosciences News Today OptiNose News Today HilleVax News Today OncoCyte News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:CVM) was last updated on 5/5/2025 by MarketBeat.com Staff From Our PartnersWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredShocking AI play that’s beats Nvidia by a country mileYou’ve seen the headlines about Nvidia. Now Tim Sykes is sounding the alarm — because what CEO Jensen Huang is...Timothy Sykes | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | SponsoredHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredU.S. Stock Market Now on Verge of CollapseThe last time the U.S. economy looked like this, stocks didn't move for 16 years... And many investors lost...Stansberry Research | SponsoredTrump announcement boosts “next Bitcoin”President Trump just made his first big crypto move ... Announcing the creation of a national strategic re...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CEL-SCI Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share CEL-SCI With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy CVM Stock Free CVM Stock Alerts